MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Using Long read sequencing to identify complex structural variants in PRKN-PD

K. Daida, M. Funayama, A. Miano-Burkhardt, L. Mailik, K. Billingsley, M. Ishiguro, H. Yoshino, K. Ogaki, G. Oyama, R. Nonaka, W. Akamatsu, C. Blauwendraat, N. Hattori (Bethesda, USA)

Meeting: 2023 International Congress

Abstract Number: 1072

Keywords: Familial neurodegenerative diseases, Parkinson’s, Parkinsonism

Category: Parkinson's Disease: Genetics

Objective: Identify complex structural variants in PRKN gene from Parkinson’s disease patients.

Background: PRKN is the most frequent causative gene in young onset Parkinson’s disease (YOPD) and autosomal recessive PD. Biallelic PRKN patients typically present young or juvenile-onset Parkinsonism. The role of heterozygous PRKN variants in sporadic PD is controversial; where some reports show an increased risk of carrying a single damaging variant, and others report no effect. As it is a widespread pathogenic gene in YOPD, PRKN is considered a potential target for gene therapy. Therefore, it is crucial to identify PD patients harboring PRKN variants. PRKN is located in FRA6E, one of the most common fragile sites in the human genome, making this region prone to structural variants. Structural variants are prevalent in PRKN variants, mainly deletions, and duplication. There are patients where only one variant is identified although they fit in the typical PRKN phenotype and have YOPD. We hypothesized complex structural variants of PRKN, which conventional sequencing methods cannot identify, exist as an unrevealed second mutation in such YOPD cases.

Method: To identify the causative variant in PRKN from PD subjects, we used targeted resequencing for PD-related genes, multiplex ligation-dependent probe amplification (MLPA), and/or short-read whole exome sequencing (WES). PD subjects only harbor heterozygous PRKN variants, without other known causative variants in PD-related genes, were performed long read whole genome sequencing. To confirm the identified variants by long-read sequencing, Sanger sequencing was performed.

Results: Long-read sequencing identified large structural variants which MLPA and short-read WES could not determine from YOPD subjects. YOPD subjects with the large structural variant presented typical PRKN-PD presentation; young onset, good response to levodopa, and lower limb dystonia.

Conclusion: This study suggests that PRKN structural variants cannot be identified by conventional short-read sequencing methods but can be identified by long-read sequencing. Long-read sequencing may expand the role of the PRKN gene in PD.

To cite this abstract in AMA style:

K. Daida, M. Funayama, A. Miano-Burkhardt, L. Mailik, K. Billingsley, M. Ishiguro, H. Yoshino, K. Ogaki, G. Oyama, R. Nonaka, W. Akamatsu, C. Blauwendraat, N. Hattori. Using Long read sequencing to identify complex structural variants in PRKN-PD [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/using-long-read-sequencing-to-identify-complex-structural-variants-in-prkn-pd/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/using-long-read-sequencing-to-identify-complex-structural-variants-in-prkn-pd/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley